Pancreatic Trypsinogen and Cathepsin B in Pancreatic Cancer
Author Information
Author(s): T. Ohta, T. Terada, T. Nagakawa, H. Tajima, H. Itohl, L. Fonseca, I. Miyazaki
Primary Institution: School of Medicine, Kanazawa University
Hypothesis
Do pancreatic invasive ductal adenocarcinomas express pancreatic trypsinogen and cathepsin B?
Conclusion
The study found that pancreatic invasive ductal adenocarcinomas express pancreatic trypsinogen and cathepsin B, suggesting their potential roles in cancer invasion and metastasis.
Supporting Evidence
- 75% of invasive tubular adenocarcinomas expressed pancreatic trypsinogen.
- 70% of invasive tubular adenocarcinomas expressed cathepsin B.
- None of the intraductal papillary adenocarcinomas expressed pancreatic trypsinogen or cathepsin B.
Takeaway
This study looked at cancer cells from the pancreas and found that they make certain proteins that might help them spread.
Methodology
Immunohistochemical evaluation of pancreatic trypsinogen and cathepsin B in surgically resected pancreatic ductal adenocarcinomas.
Limitations
The study may have been affected by delayed fixation of specimens, which could compromise results.
Participant Demographics
16 men and 7 women, aged 33 to 77 years, mean age 62 years.
Statistical Information
P-Value
<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website